v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
OPERATING EXPENSES    
Research and development $ 1,854 $ 335
Selling, general and administrative 3,780 1,042
Total operating expenses 5,634 1,377
Loss from operations (5,634) (1,377)
OTHER (EXPENSE) INCOME    
Change in fair value of derivative liability 33 0
Interest income 24 4
Interest expense (648) 0
Net other (expense) income (591) 4
Net loss from operations before discontinued operations (6,225) (1,373)
Income (loss) from discontinued operations 23 (129)
Net loss $ (6,202) $ (1,502)
Net loss per share attributed to common stockholders - basic and diluted (in dollars per share) $ (2.23) $ (2.52)
Weighted-average number of shares - basic and diluted (in shares) 2,883,650 569,368